All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Stage IB Pancreatic Cancer AJCC v6 and v7 | NCIT_C88101 | [Stage IB includes: T2, N0, M0. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)] |
| Grade 1 Stokes-Adams Syndrome, CTCAE | NCIT_C54797 | |
| Stokes-Adams Syndrome, CTCAE | NCIT_C54942 | |
| Stage IIA Pancreatic Cancer AJCC v6 and v7 | NCIT_C88102 | [Stage IIA includes: T3, N0, M0. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)] |
| Stage II Pancreatic Cancer AJCC v6 and v7 | NCIT_C7786 | [Stage II includes: IIA (T3, N0, M0); IIB (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor limited to the pancreas 2 cm or less in greatest dimension. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.)] |
| Grade 1 Supraventricular Arrhythmia NOS, CTCAE | NCIT_C54798 | |
| Supraventricular Arrhythmia NOS, CTCAE | NCIT_C54943 | |
| Grade 1 Supraventricular Extrasystoles, CTCAE | NCIT_C54799 | |
| Supraventricular Extrasystoles, CTCAE | NCIT_C54944 | [An adverse event characterized by premature atrial contractions of the heart caused by signals originating from ectopic atrial sites or the atrioventricular node.] |
| HEXIM1 wt Allele | NCIT_C112916 | [Human HEXIM1 wild-type allele is located in the vicinity of 17q21.31 and is approximately 5 kb in length. This allele, which encodes protein HEXIM1, plays a role in transcriptional repression.] |
| HEXIM1 Gene | NCIT_C112915 | [This gene is involved in the modulation of gene transcription.] |
| 17q21.31 | NCIT_C44520 | [A chromosome band present on 17q] |
| Protein HEXIM1 | NCIT_C112917 | [Protein HEXIM1 (359 aa, ~41 kDa) is encoded by the human HEXIM1 gene. This protein is involved in the inhibition of transcription by RNA polymerase II.] |
| Accessory | NCIT_C112918 | [Something added to extend a whole and to make an addition.] |
| Clinical Target Volume | NCIT_C112912 | [The tissue volume that contains a demonstrable gross target volume and/or sub-clinical microscopic malignant disease, which has to be eliminated. This volume must be treated adequately in order to achieve the aim of therapy, cure or palliation.] |
| Gross Target Volume | NCIT_C112913 | [The gross palpable or visible/demonstrable extent and location of malignant growth.] |
| Radiotherapy Bolus | NCIT_C112914 | [A tissue-equivalent material placed in contact with the skin to increase the surface dose and/or compensate for missing tissue. A bolus can also be used to compensate for lack of scatter, such as near the extremities or the head during total-body irradiation.] |
| Grade 1 Palpitations, CTCAE | NCIT_C54790 | [Mild symptoms; intervention not indicated] |
| Palpitations, CTCAE | NCIT_C54935 | [A disorder characterized by an unpleasant sensation of irregular and/or forceful beating of the heart.] |
| Grade 1 Prolonged QTc Interval, CTCAE | NCIT_C54791 |